Safety and Efficacy Study of Vigabatrin to Treat Methamphetamine Dependence
Public ClinicalTrials.gov record NCT00730522. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Vigabatrin for Treatment of Methamphetamine Dependence: A Phase II Study
Study identification
- NCT ID
- NCT00730522
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Catalyst Pharmaceuticals, Inc.
- Industry
- Enrollment
- 55 participants
Conditions and interventions
Conditions
Interventions
- CPP-109 vigabatrin Drug
- Matching Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2008
- Primary completion
- May 31, 2009
- Completion
- Oct 31, 2009
- Last update posted
- Dec 8, 2020
2008 – 2009
United States locations
- U.S. sites
- 8
- U.S. states
- 6
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| North County Clinical Research (NCCR) | Oceanside | California | — | — |
| South Bay Treatment Center | San Diego | California | — | — |
| Addiction Pharmacology Research Laboratory, St. Luke's Hospital | San Francisco | California | — | — |
| START Research and Treatment | Kansas City | Missouri | — | — |
| Creighton University Medical Center | Omaha | Nebraska | — | — |
| Behavioral Health Research Center of the Southwest | Albuquerque | New Mexico | — | — |
| Pahl Pharmaceutical Research | Oklahoma City | Oklahoma | — | — |
| Pillar Research | Dallas | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00730522, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 8, 2020 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00730522 live on ClinicalTrials.gov.